Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials

Image Source : AP Serum Institute of India has been asked by DCGI to revise its protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials in India. Serum Institute of India (SII), who earlier sought permission to conduct Phase-2 and 3 trials of Oxford University’s coronavirus vaccine in…

Read More Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials